483
Recipharm MontsRecipharm Monts – FDA 483, Feb 26, 2013
Record Details
Recipharm Monts, a drug product manufacturer in Monts, France, was cited for significant deficiencies in equipment design, maintenance, and procedural adherence during an FDA inspection. Observations included malfunctioning visual inspection systems leading to miscounts, inadequate complaint handling procedures, and a deficient stability testing program. These issues indicate a lack of control over critical manufacturing and quality processes.
View Company Profile
ID · 01138d7a-dab5-495d-a5da-6e0f03eb5d1e
Other documents for Recipharm Monts
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.